Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes
about
Alzheimer mechanisms and therapeutic strategiesSex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct?Functional network endophenotypes unravel the effects of apolipoprotein E epsilon 4 in middle-aged adultsAlzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetesFamily history and APOE-4 genetic risk in Alzheimer's disease.Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele.Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older.Mid-life Cardiovascular Risk Impacts Memory Function: The Framingham Offspring Study.Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adultsApolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.ApoE and pulse pressure interactively influence level and change in the aging of episodic memory: Protective effects among ε2 carriersBlood pressure is associated with higher brain amyloid burden and lower glucose metabolism in healthy late middle-age personsAberrant functional connectivity in Papez circuit correlates with memory performance in cognitively intact middle-aged APOE4 carriersThe Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort.Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study.Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.Blood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.Appraisal of cognition in preclinical Alzheimer's disease: a conceptual review.New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degenerationLongitudinal modeling of cognitive aging and the TOMM40 effect.The role of APOE in cerebrovascular dysfunctionGlucose Dysregulation Interacts With APOE-∊4 to Potentiate Temporoparietal Cortical ThinningAPOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death.Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele.Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects.Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies.Impact of Personality on Cognitive Aging: A Prospective Cohort Study.
P2860
Q22252311-E295E1CC-575D-4C97-A809-473424041DA4Q27302017-2A334427-7814-4D6F-845D-A3CD2C28A678Q28394313-21B0F6E3-3F43-4A64-AF65-4CFCFF0E4307Q34039983-034B5B5D-C218-4858-A5DC-8BE48CBE878CQ34044849-7FBA9896-3F70-402B-B1A7-56EC2C13B788Q34167647-11318634-26F6-47DA-89D5-0C045A811B0BQ34303501-4669308A-9C26-4F67-975F-153A82C5010DQ34364232-182311B7-9B14-4DFF-842E-6C23FFC6C8C1Q34725320-E5B4D721-BE35-4377-9A59-55FB7EC5C89CQ35075501-7D2BB9FB-5A10-4068-BA5C-F6C1DB9E9C8CQ35133412-31132B81-DF3B-4995-82F5-48875DD427F3Q35167347-77E3CCED-D225-4EF9-BD30-1E21366F850BQ35523936-7542FF98-D7B6-4419-A134-F125AE58CF96Q35572281-30DFAD08-E110-466E-896A-6E0E101DF736Q35610181-B4C7CD56-42FD-4719-BDFC-3A5D05661447Q35664370-F8A16524-A391-4BD5-82FE-46B17E8C908EQ35888120-A5ECAEA9-8A1E-4F2B-A1AC-FAB99C2EC8A2Q35985867-8AC39B4A-537F-4F43-9831-6A74598AB405Q35991723-DFB9AE99-6E75-4A1D-945B-643D7543FD88Q35995579-E3ECB29A-A510-4109-97CB-DE8332CAF51BQ36090201-E967A6C2-F2C2-4665-A090-3BBC33E1B55DQ36218610-DBF9F0AB-7E59-43F9-AFA8-6005ADF7B064Q36354926-25B47511-1557-4D83-9501-2BC9F9B71E65Q36813704-4A584DDD-BEB2-4A84-AF24-9FDF9A2A97ADQ37019867-5BB6427E-25D6-47DC-8FFC-40E3E38FD79FQ37154399-3A22913D-832F-44E1-845F-43DF1D51B99BQ37415248-2A9A7DF2-70EB-488D-9521-302EB0915FC6Q37671051-5220CAB3-A8D1-4564-91BE-3CDC58A02AE8Q38150812-F65F5EB9-0D59-45AA-8B67-3F8912CEFA25Q38287482-EE199A43-A238-4C26-AD34-95843AB0F280Q47714679-7A2B0718-7665-407F-B5FC-17E71BA96167
P2860
Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@ast
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@en
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@nl
type
label
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@ast
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@en
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@nl
prefLabel
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@ast
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@en
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@nl
P2093
P2860
P1433
P1476
Cerebrovascular risk factors a ...... in healthy APOE ε4 homozygotes
@en
P2093
B K Woodruff
C Hoffman-Snyder
E M Reiman
L C Baxter
M N Sabbagh
R J Caselli
R Rademakers
P2860
P304
P356
10.1212/WNL.0B013E318211C3AE
P407
P577
2011-02-16T00:00:00Z